Spektus Pharma
Spektus Pharma and GEBRO Holding Announce Global Commercialization Partnership for ActraFlex®
Novel twice-daily extended-release tramadol/paracetamol formulation combines Spektus' proprietary AmyloFlex® technology with GEBRO's established…
